A study was conducted on 40 patients with atrial fibrillation undergoing electrical cardioversion and found that NT-proBNP levels above 1707 pg/ml had a specificity of 92% and a sensitivity of 36% in predicting recurrence of atrial fibrillation 6 months after a successful cardioversion (35). This evidence concerns the gene NPPB and atrial fibrillation.